Retrospective study of 194 patients with initially unresectable, pMMR colorectal liver metastases found that RAS mutation status was associated with early progression or recurrence after conversion therapy. (Front Surg)
RAS mutation linked to early progression in liver metastases conversion therapy
The CRC Digest